The executive order establishes the MAHA Commission, a coalition including the FDA, NIH, and CDC, tasked with developing a sweeping national strategy to combat chronic disease. This includes reassessing nutrition, physical activity, pharmaceutical use, and environmental exposure across all levels of childhood health. A core objective is transparency — protecting science from “inappropriate influence” and reevaluating how medications like SSRIs...